Rocket Pharmaceuticals, Inc. Income Taxes Paid
Rocket Pharmaceuticals, Inc. (RCKT) reported Income Taxes Paid of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-02-26
- Rocket Pharmaceuticals, Inc. income taxes paid, net for the quarter ending 2019-12-31 was $26.00K.
- Rocket Pharmaceuticals, Inc. income taxes paid, net for the quarter ending 2018-12-31 was $0.00.
- Rocket Pharmaceuticals, Inc. income taxes paid, net for the quarter ending 2018-09-30 was $2.00K.
- Rocket Pharmaceuticals, Inc. income taxes paid, net for the quarter ending 2018-06-30 was $0.00.
- Rocket Pharmaceuticals, Inc. income taxes paid, net for fiscal 2025 was $0.00.
- Rocket Pharmaceuticals, Inc. income taxes paid, net for fiscal 2021 was $0.00.
- Rocket Pharmaceuticals, Inc. income taxes paid, net for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Rocket Pharmaceuticals, Inc. income taxes paid, net for fiscal 2019 was $26.00K, a 1200.00% increase from fiscal 2018.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 | |||
| 2021-12-31 | $0.00 10-K · filed 2022-02-28 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-02-28 | |||
| 2019-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $26.00K 10-K · filed 2022-02-28 | ||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-08 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $2.00K derived: sum of 2 quarters · filed 2021-03-01 | $2.00K derived: sum of 3 quarters · filed 2021-03-01 | $2.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $2.00K derived: sum of 2 quarters · filed 2019-11-08 | $2.00K 10-Q · filed 2019-11-08 | $2.00K derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $0.00 10-Q · filed 2018-08-14 | $0.00 derived: sum of 3 quarters · filed 2019-03-08 | $0.00 derived: sum of 4 quarters · filed 2019-03-08 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-11 | $0.00 derived: sum of 2 quarters · filed 2019-03-08 | $0.00 derived: sum of 3 quarters · filed 2019-03-08 | $0.00 derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $0.00 derived: sum of 2 quarters · filed 2019-03-08 | $0.00 derived: sum of 3 quarters · filed 2019-03-08 | $0.00 10-K · filed 2019-03-08 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $0.00 derived: sum of 2 quarters · filed 2018-11-09 | $0.00 10-Q · filed 2018-11-09 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $0.00 10-Q · filed 2018-08-14 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-11 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |